Skip to contentSkip to Braille Studio

Library / Laws / 117th Congress / House Bills / H.R. 1730

H.R. 1730

To amend the Federal Food, Drug, and Cosmetic Act to accelerate development of therapies across the spectrum of rare diseases and conditions and facilitate patient access to such therapies, and for other purposes.

Print stageDateSize⠃
Introduced in House2021-03-1013.1K⠃⠗⠋